Telegenomics is a virtual visit that gives physicians precision insights into care

The U.S. Food and Drug Administration's validation requirements process for drug development is a good model for healthcare artificial intelligence governance, explains Michael Abrams, managing partner at Numerof & Associates.

The chief information officer of the 25-bed New Mexico nonprofit discusses plan for some new clinical automation tools. He also describes how he's using AI to help with network defense, and how that's enabling gains in other areas.

Sergio Calvo, general manager of theranostics at GE HealthCare, discusses the company's role in developing and investing in theranostics and how the field could evolve to enable even more precise, individualized treatment strategies.